News & Events
There has been change in ownership of management of Unimark Remedies Ltd. It is now 100% owned and managed by Shamrock Pharmagroup
There has been change in ownership of management of Unimark Remedies Ltd. It is now 100% owned and managed by Shamrock Pharmagroup
There has been change in ownership of management of Unimark Remedies Ltd. It is now 100% owned and managed by Shamrock Pharmagroup
There has been change in ownership of management of Unimark Remedies Ltd. It is now 100% owned and managed by Shamrock Pharmagroup
There has been change in ownership of management of Unimark Remedies Ltd. It is now 100% owned and managed by Shamrock Pharmagroup
APIs (Active Pharmaceutical Ingredients)
At Unimark Remedies, we specialize in the development and production of Active Pharmaceutical Ingredients (APIs). APIs are the cornerstone of pharmaceutical formulations, serving as the biologically active components that deliver therapeutic effects
Explore our website to learn more about our range of APIs and how we can partner with you to bring your pharmaceutical products to life.
Carbapenems
- Broad spectrum β-lactam antibiotics
- Leading developer of Carbapenems at USFDA compliant facility
- In-house production of Intermediates & Side Chains (No dependency on imports)
- Dedicated facility for Carbapenems / Orals Sterile / APIs / FDF
- Largest Integrated Plant from Chemical to Vials (Sterile)
- Dedicated R&D for Carbapenems
- USFDA / EUGMP / PMDA / KFDA / MHRA / TGA compliant
- 16 DMFs (Technical & Sterile) for Carbapenems
Under Renewal
Under Renewal